Volume 83, Issue 1, Pages 160-166 (January 2013) Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community Johan Ärnlöv, Axel C. Carlsson, Johan Sundström, Erik Ingelsson, Anders Larsson, Lars Lind, Tobias E. Larsson Kidney International Volume 83, Issue 1, Pages 160-166 (January 2013) DOI: 10.1038/ki.2012.327 Copyright © 2013 International Society of Nephrology Terms and Conditions
Figure 1 Spline curve showing the relationship between fibroblast growth factor-23 (FGF23) and risk of cardiovascular mortality in the ULSAM cohort. Q, quintile. Kidney International 2013 83, 160-166DOI: (10.1038/ki.2012.327) Copyright © 2013 International Society of Nephrology Terms and Conditions
Figure 2 Curve showing the cumulative incidence of cardiovascular mortality in the ULSAM cohort by above versus below the fifth quintile of fibroblast growth factor-23. Log-rank P=0.0002. Q, quintile. Kidney International 2013 83, 160-166DOI: (10.1038/ki.2012.327) Copyright © 2013 International Society of Nephrology Terms and Conditions